K Huber Selected Research

K Huber Research Topics

Disease

17	Myocardial Infarction 02/2021 - 03/2000
12	Thrombosis (Thrombus) 12/2014 - 04/2001
10	Hemorrhage 09/2014 - 08/2001
10	Acute Coronary Syndrome 01/2014 - 08/2000
9	Inflammation (Inflammations) 08/2023 - 07/2000
9	Insulin Resistance 09/2018 - 09/2001
8	Cardiovascular Diseases (Cardiovascular Disease) 06/2013 - 09/2001
8	Coronary Artery Disease (Coronary Atherosclerosis) 05/2011 - 05/2000
6	ST Elevation Myocardial Infarction 02/2021 - 12/2008
6	Atrial Fibrillation 08/2016 - 05/2013
5	Stroke (Strokes) 08/2016 - 10/2010
4	Atherosclerosis 11/2017 - 09/2001
4	Hypertension (High Blood Pressure) 08/2016 - 03/2000
4	Atherosclerotic Plaque (Atheroma) 06/2014 - 08/2006
4	Pain (Aches) 09/2005 - 03/2000
3	Diabetes Mellitus 05/2012 - 03/2000
3	Unstable Angina 04/2001 - 12/2000
2	Neoplasms (Cancer) 01/2017 - 03/2001
2	Heart Failure 08/2016 - 02/2010
2	Body Weight (Weight, Body) 01/2015 - 05/2007
2	Coronary Disease (Coronary Heart Disease) 05/2013 - 11/2012
2	Rupture 03/2011 - 08/2006
2	Reperfusion Injury 01/2010 - 07/2000
2	Postoperative Pain 09/2005 - 08/2001
2	Infections 07/2002 - 03/2001
2	Hypertriglyceridemia 09/2001 - 09/2001
2	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 09/2001 - 07/2000
2	Critical Illness (Critically Ill) 09/2001 - 07/2000
1	VLCAD deficiency 10/2021
1	Non-ST Elevated Myocardial Infarction 02/2021
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 11/2017
1	Ischemia 11/2017
1	Arterial Occlusive Diseases (Arterial Occlusive Disease) 11/2017
1	Vascular Diseases (Vascular Disease) 08/2016
1	Thromboembolism 08/2016
1	Type 2 Diabetes Mellitus (MODY) 02/2015

Drug/Important Bio-Agent (IBA)

6	Plasminogen Activator Inhibitor 1IBA 02/2015 - 09/2001
6	Clopidogrel (Plavix)FDA Link 06/2012 - 04/2001
5	Insulin (Novolin)FDA Link 09/2016 - 05/2006
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2012 - 09/2001
4	Heparin (Liquaemin)FDA LinkGeneric 08/2010 - 12/2000
4	Plasminogen InactivatorsIBA 05/2006 - 07/2001
3	Proteins (Proteins, Gene)FDA Link 08/2023 - 08/2007
3	Messenger RNA (mRNA)IBA 08/2023 - 06/2014
3	Glucose (Dextrose)FDA LinkGeneric 02/2015 - 05/2006
3	P-SelectinIBA 02/2015 - 07/2000
3	AnticoagulantsIBA 05/2014 - 05/2013
3	Prasugrel Hydrochloride FDA Link 01/2014 - 08/2010
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 06/2012 - 04/2001
3	Enoxaparin (Lovenox)FDA LinkGeneric 08/2010 - 12/2000
3	CytokinesIBA 02/2010 - 07/2000
3	Fibrinolytic Agents (Antithrombotic Agents)IBA 09/2001 - 04/2000
2	Carnitine (L-Carnitine)FDA LinkGeneric 08/2023 - 10/2021
2	AdipokinesIBA 01/2018 - 02/2015
2	Apolipoproteins E (ApoE)IBA 11/2017 - 09/2001
2	Biomarkers (Surrogate Marker)IBA 01/2017 - 03/2011
2	Nonesterified Fatty Acids (NEFA)IBA 02/2015 - 01/2013
2	RNA (Ribonucleic Acid)IBA 02/2015 - 05/2007
2	Lidocaine (Xylocaine)FDA LinkGeneric 09/2014 - 01/2010
2	Vitamin K FDA Link 05/2014 - 06/2013
2	AntigensIBA 06/2013 - 09/2001
2	omega-Chloroacetophenone (Mace)IBA 04/2012 - 12/2010
2	Abciximab (ReoPro)FDA Link 12/2011 - 12/2008
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 05/2011 - 08/2010
2	Complement System Proteins (Complement)IBA 03/2011 - 08/2006
2	Macrophage Colony-Stimulating FactorIBA 02/2010 - 12/2007
2	EnzymesIBA 08/2007 - 11/2000
2	Tissue Plasminogen Activator (Alteplase)FDA Link 05/2006 - 09/2001
2	HomocysteineIBA 01/2006 - 09/2001
2	Antifibrinolytic Agents (Antifibrinolytics)IBA 09/2001 - 09/2001
2	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 04/2001 - 12/2000
2	SelectinsIBA 03/2001 - 07/2000
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 08/2023
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 08/2023
1	Mitochondrial DNA (mtDNA)IBA 08/2023
1	Carnitine O-Palmitoyltransferase (Carnitine Palmitoyltransferase II)IBA 10/2021
1	Acyl-CoA Dehydrogenase (Medium-Chain Acyl-Coenzyme A Dehydrogenase)IBA 10/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 10/2021
1	Solute Carrier Family 22 Member 5IBA 10/2021
1	Troponin T (Troponin T1)IBA 02/2021
1	SphingomyelinsIBA 09/2018
1	Imatinib Mesylate (Gleevec)FDA Link 11/2017
1	nilotinib FDA Link 11/2017
1	AngiopoietinsIBA 11/2017
1	Phosphotransferases (Kinase)IBA 11/2017
1	ElementsIBA 09/2016
1	LipopolysaccharidesIBA 01/2016
1	AdiponectinIBA 02/2015
1	Peptide Hydrolases (Proteases)FDA Link 02/2015
1	Interleukin-18 (Interleukin 18)IBA 02/2015
1	Interleukin-8 (Interleukin 8)IBA 02/2015
1	Tissue Inhibitor of Metalloproteinase-1IBA 02/2015
1	Butyrates (Butyrate)IBA 01/2015

Therapy/Procedure

16	Therapeutics 01/2014 - 04/2000
11	Stents 12/2014 - 07/2000
6	Percutaneous Coronary Intervention 12/2014 - 02/2010
6	Thrombolytic Therapy 08/2010 - 04/2000
2	Electric Countershock (Cardioversion) 08/2016 - 05/2013
2	Tonsillectomy 09/2005 - 08/2001
2	Cardiopulmonary Resuscitation (CPR) 09/2001 - 07/2000